nodes	percent_of_prediction	percent_of_DWPC	metapath
Emedastine—Sinus headache—Sitagliptin—type 2 diabetes mellitus	0.0438	0.0451	CcSEcCtD
Emedastine—Bad taste—Irbesartan—type 2 diabetes mellitus	0.0332	0.0341	CcSEcCtD
Emedastine—Sinus headache—Metformin—type 2 diabetes mellitus	0.0272	0.028	CcSEcCtD
Emedastine—Sinusitis—Repaglinide—type 2 diabetes mellitus	0.00974	0.01	CcSEcCtD
Emedastine—Stinging—Losartan—type 2 diabetes mellitus	0.00973	0.01	CcSEcCtD
Emedastine—Rhinitis—Repaglinide—type 2 diabetes mellitus	0.00935	0.00961	CcSEcCtD
Emedastine—Sinusitis—Rosiglitazone—type 2 diabetes mellitus	0.00921	0.00947	CcSEcCtD
Emedastine—Eye disorder—Repaglinide—type 2 diabetes mellitus	0.00871	0.00896	CcSEcCtD
Emedastine—Cardiac disorder—Repaglinide—type 2 diabetes mellitus	0.00865	0.0089	CcSEcCtD
Emedastine—Discomfort—Tolazamide—type 2 diabetes mellitus	0.00851	0.00875	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Linagliptin—type 2 diabetes mellitus	0.00847	0.00871	CcSEcCtD
Emedastine—Eye disorder—Rosiglitazone—type 2 diabetes mellitus	0.00823	0.00847	CcSEcCtD
Emedastine—Cardiac disorder—Rosiglitazone—type 2 diabetes mellitus	0.00818	0.00841	CcSEcCtD
Emedastine—Skin disorder—Linagliptin—type 2 diabetes mellitus	0.00794	0.00817	CcSEcCtD
Emedastine—Olanzapine—ADRA2A—type 2 diabetes mellitus	0.00793	0.288	CrCbGaD
Emedastine—Rhinitis—Glipizide—type 2 diabetes mellitus	0.00773	0.00795	CcSEcCtD
Emedastine—Sinusitis—Pioglitazone—type 2 diabetes mellitus	0.00772	0.00794	CcSEcCtD
Emedastine—Sinusitis—Sitagliptin—type 2 diabetes mellitus	0.0075	0.00771	CcSEcCtD
Emedastine—Olanzapine—HTR2C—type 2 diabetes mellitus	0.0073	0.265	CrCbGaD
Emedastine—Eye disorder—Glipizide—type 2 diabetes mellitus	0.00721	0.00741	CcSEcCtD
Emedastine—Eye disorder—Pioglitazone—type 2 diabetes mellitus	0.00691	0.0071	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Repaglinide—type 2 diabetes mellitus	0.00686	0.00706	CcSEcCtD
Emedastine—Cardiac disorder—Pioglitazone—type 2 diabetes mellitus	0.00686	0.00705	CcSEcCtD
Emedastine—Sinusitis—Bromocriptine—type 2 diabetes mellitus	0.00679	0.00698	CcSEcCtD
Emedastine—Eye disorder—Sitagliptin—type 2 diabetes mellitus	0.00671	0.0069	CcSEcCtD
Emedastine—Cardiac disorder—Sitagliptin—type 2 diabetes mellitus	0.00666	0.00685	CcSEcCtD
Emedastine—Rhinitis—Bromocriptine—type 2 diabetes mellitus	0.00651	0.00669	CcSEcCtD
Emedastine—Skin disorder—Repaglinide—type 2 diabetes mellitus	0.00643	0.00662	CcSEcCtD
Emedastine—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00642	0.00661	CcSEcCtD
Emedastine—Rash—Miglitol—type 2 diabetes mellitus	0.00637	0.00655	CcSEcCtD
Emedastine—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00636	0.00654	CcSEcCtD
Emedastine—Vision blurred—Glipizide—type 2 diabetes mellitus	0.00633	0.00651	CcSEcCtD
Emedastine—Mental disorder—Sitagliptin—type 2 diabetes mellitus	0.00629	0.00646	CcSEcCtD
Emedastine—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.00614	0.00631	CcSEcCtD
Emedastine—Eye disorder—Bromocriptine—type 2 diabetes mellitus	0.00607	0.00624	CcSEcCtD
Emedastine—Cardiac disorder—Bromocriptine—type 2 diabetes mellitus	0.00603	0.0062	CcSEcCtD
Emedastine—Asthenia—Tolazamide—type 2 diabetes mellitus	0.00593	0.00609	CcSEcCtD
Emedastine—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.0059	0.00607	CcSEcCtD
Emedastine—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.00589	0.00605	CcSEcCtD
Emedastine—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00584	0.00601	CcSEcCtD
Emedastine—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00584	0.00601	CcSEcCtD
Emedastine—Rash—Tolbutamide—type 2 diabetes mellitus	0.00572	0.00589	CcSEcCtD
Emedastine—Mental disorder—Bromocriptine—type 2 diabetes mellitus	0.00569	0.00585	CcSEcCtD
Emedastine—Headache—Tolbutamide—type 2 diabetes mellitus	0.00569	0.00585	CcSEcCtD
Emedastine—Discomfort—Glipizide—type 2 diabetes mellitus	0.00565	0.00581	CcSEcCtD
Emedastine—Sinusitis—Gliclazide—type 2 diabetes mellitus	0.00557	0.00573	CcSEcCtD
Emedastine—Eye disorder—Glyburide—type 2 diabetes mellitus	0.00555	0.0057	CcSEcCtD
Emedastine—Dysgeusia—Bromocriptine—type 2 diabetes mellitus	0.00554	0.00569	CcSEcCtD
Emedastine—Olanzapine—CYP1A2—type 2 diabetes mellitus	0.00551	0.2	CrCbGaD
Emedastine—Asthenia—Nateglinide—type 2 diabetes mellitus	0.00549	0.00565	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.00544	0.00559	CcSEcCtD
Emedastine—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00541	0.00557	CcSEcCtD
Emedastine—Discomfort—Pioglitazone—type 2 diabetes mellitus	0.00541	0.00556	CcSEcCtD
Emedastine—Rhinitis—Gliclazide—type 2 diabetes mellitus	0.00534	0.0055	CcSEcCtD
Emedastine—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.00533	0.00548	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.00528	0.00543	CcSEcCtD
Emedastine—Discomfort—Sitagliptin—type 2 diabetes mellitus	0.00525	0.0054	CcSEcCtD
Emedastine—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00521	0.00536	CcSEcCtD
Emedastine—Rash—Tolazamide—type 2 diabetes mellitus	0.00521	0.00536	CcSEcCtD
Emedastine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00517	0.00532	CcSEcCtD
Emedastine—Headache—Tolazamide—type 2 diabetes mellitus	0.00517	0.00532	CcSEcCtD
Emedastine—Rash—Linagliptin—type 2 diabetes mellitus	0.00515	0.0053	CcSEcCtD
Emedastine—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00515	0.0053	CcSEcCtD
Emedastine—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.00515	0.00529	CcSEcCtD
Emedastine—Headache—Linagliptin—type 2 diabetes mellitus	0.00512	0.00527	CcSEcCtD
Emedastine—Sinusitis—Valsartan—type 2 diabetes mellitus	0.00512	0.00526	CcSEcCtD
Emedastine—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.0051	0.00524	CcSEcCtD
Emedastine—Sinusitis—Orlistat—type 2 diabetes mellitus	0.00506	0.0052	CcSEcCtD
Emedastine—Rash—Acarbose—type 2 diabetes mellitus	0.005	0.00515	CcSEcCtD
Emedastine—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.005	0.00514	CcSEcCtD
Emedastine—Dermatitis—Acarbose—type 2 diabetes mellitus	0.005	0.00514	CcSEcCtD
Emedastine—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00499	0.00513	CcSEcCtD
Emedastine—Eye disorder—Gliclazide—type 2 diabetes mellitus	0.00498	0.00512	CcSEcCtD
Emedastine—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.00495	0.00509	CcSEcCtD
Emedastine—Rhinitis—Valsartan—type 2 diabetes mellitus	0.00491	0.00505	CcSEcCtD
Emedastine—Vision blurred—Glyburide—type 2 diabetes mellitus	0.00487	0.00501	CcSEcCtD
Emedastine—Rash—Nateglinide—type 2 diabetes mellitus	0.00482	0.00496	CcSEcCtD
Emedastine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00482	0.00496	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.00478	0.00491	CcSEcCtD
Emedastine—Pain—Glipizide—type 2 diabetes mellitus	0.00469	0.00482	CcSEcCtD
Emedastine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00469	0.00482	CcSEcCtD
Emedastine—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.00467	0.0048	CcSEcCtD
Emedastine—Cardiac disorder—Valsartan—type 2 diabetes mellitus	0.00454	0.00467	CcSEcCtD
Emedastine—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.00452	0.00465	CcSEcCtD
Emedastine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.0045	0.00463	CcSEcCtD
Emedastine—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.00449	0.00462	CcSEcCtD
Emedastine—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.00448	0.00461	CcSEcCtD
Emedastine—Rhinitis—Metformin—type 2 diabetes mellitus	0.00447	0.0046	CcSEcCtD
Emedastine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00443	0.00455	CcSEcCtD
Emedastine—Pain—Sitagliptin—type 2 diabetes mellitus	0.00436	0.00448	CcSEcCtD
Emedastine—Mental disorder—Valsartan—type 2 diabetes mellitus	0.00429	0.00441	CcSEcCtD
Emedastine—Mental disorder—Orlistat—type 2 diabetes mellitus	0.00424	0.00436	CcSEcCtD
Emedastine—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.00422	0.00434	CcSEcCtD
Emedastine—Rash—Repaglinide—type 2 diabetes mellitus	0.00418	0.00429	CcSEcCtD
Emedastine—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.00417	0.00429	CcSEcCtD
Emedastine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00417	0.00429	CcSEcCtD
Emedastine—Eye disorder—Metformin—type 2 diabetes mellitus	0.00417	0.00429	CcSEcCtD
Emedastine—Headache—Repaglinide—type 2 diabetes mellitus	0.00415	0.00427	CcSEcCtD
Emedastine—Sinusitis—Losartan—type 2 diabetes mellitus	0.00414	0.00426	CcSEcCtD
Emedastine—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.00414	0.00426	CcSEcCtD
Emedastine—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00414	0.00425	CcSEcCtD
Emedastine—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.00412	0.00424	CcSEcCtD
Emedastine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.00402	0.00413	CcSEcCtD
Emedastine—Rhinitis—Losartan—type 2 diabetes mellitus	0.00397	0.00408	CcSEcCtD
Emedastine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00397	0.00408	CcSEcCtD
Emedastine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00395	0.00406	CcSEcCtD
Emedastine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00394	0.00405	CcSEcCtD
Emedastine—Asthenia—Glipizide—type 2 diabetes mellitus	0.00393	0.00404	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00392	0.00403	CcSEcCtD
Emedastine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00392	0.00403	CcSEcCtD
Emedastine—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.00391	0.00402	CcSEcCtD
Emedastine—Discomfort—Gliclazide—type 2 diabetes mellitus	0.0039	0.00401	CcSEcCtD
Emedastine—Pruritus—Glipizide—type 2 diabetes mellitus	0.00388	0.00399	CcSEcCtD
Emedastine—Dysgeusia—Metformin—type 2 diabetes mellitus	0.0038	0.00391	CcSEcCtD
Emedastine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00377	0.00387	CcSEcCtD
Emedastine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00371	0.00382	CcSEcCtD
Emedastine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.0037	0.0038	CcSEcCtD
Emedastine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.00368	0.00378	CcSEcCtD
Emedastine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00367	0.00377	CcSEcCtD
Emedastine—Vision blurred—Metformin—type 2 diabetes mellitus	0.00366	0.00376	CcSEcCtD
Emedastine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00366	0.00376	CcSEcCtD
Emedastine—Olanzapine—CYP3A4—type 2 diabetes mellitus	0.00365	0.132	CrCbGaD
Emedastine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00362	0.00372	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.0036	0.00371	CcSEcCtD
Emedastine—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.00359	0.00369	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00356	0.00366	CcSEcCtD
Emedastine—Sinusitis—Ramipril—type 2 diabetes mellitus	0.00355	0.00365	CcSEcCtD
Emedastine—Discomfort—Orlistat—type 2 diabetes mellitus	0.00354	0.00364	CcSEcCtD
Emedastine—Rash—Glipizide—type 2 diabetes mellitus	0.00346	0.00355	CcSEcCtD
Emedastine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00345	0.00355	CcSEcCtD
Emedastine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00345	0.00355	CcSEcCtD
Emedastine—Headache—Glipizide—type 2 diabetes mellitus	0.00343	0.00353	CcSEcCtD
Emedastine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00341	0.00351	CcSEcCtD
Emedastine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00338	0.00348	CcSEcCtD
Emedastine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.00338	0.00347	CcSEcCtD
Emedastine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00337	0.00347	CcSEcCtD
Emedastine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00334	0.00343	CcSEcCtD
Emedastine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00331	0.0034	CcSEcCtD
Emedastine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00329	0.00338	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.00328	0.00338	CcSEcCtD
Emedastine—Discomfort—Metformin—type 2 diabetes mellitus	0.00327	0.00336	CcSEcCtD
Emedastine—Vision blurred—Losartan—type 2 diabetes mellitus	0.00325	0.00334	CcSEcCtD
Emedastine—Pain—Gliclazide—type 2 diabetes mellitus	0.00324	0.00333	CcSEcCtD
Emedastine—Rash—Glimepiride—type 2 diabetes mellitus	0.00322	0.00332	CcSEcCtD
Emedastine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00322	0.00331	CcSEcCtD
Emedastine—Rash—Sitagliptin—type 2 diabetes mellitus	0.00321	0.00331	CcSEcCtD
Emedastine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00321	0.0033	CcSEcCtD
Emedastine—Headache—Glimepiride—type 2 diabetes mellitus	0.0032	0.00329	CcSEcCtD
Emedastine—Headache—Sitagliptin—type 2 diabetes mellitus	0.00319	0.00328	CcSEcCtD
Emedastine—Olanzapine—ALB—type 2 diabetes mellitus	0.00318	0.115	CrCbGaD
Emedastine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00311	0.0032	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.0031	0.00319	CcSEcCtD
Emedastine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00308	0.00317	CcSEcCtD
Emedastine—Skin disorder—Metformin—type 2 diabetes mellitus	0.00308	0.00316	CcSEcCtD
Emedastine—Asthenia—Glyburide—type 2 diabetes mellitus	0.00303	0.00311	CcSEcCtD
Emedastine—Pruritus—Glyburide—type 2 diabetes mellitus	0.00298	0.00307	CcSEcCtD
Emedastine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.00298	0.00306	CcSEcCtD
Emedastine—Pain—Orlistat—type 2 diabetes mellitus	0.00294	0.00302	CcSEcCtD
Emedastine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00293	0.00302	CcSEcCtD
Emedastine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00292	0.003	CcSEcCtD
Emedastine—Rash—Bromocriptine—type 2 diabetes mellitus	0.00291	0.00299	CcSEcCtD
Emedastine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00291	0.00299	CcSEcCtD
Emedastine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.0029	0.00299	CcSEcCtD
Emedastine—Discomfort—Losartan—type 2 diabetes mellitus	0.0029	0.00298	CcSEcCtD
Emedastine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.00289	0.00298	CcSEcCtD
Emedastine—Headache—Bromocriptine—type 2 diabetes mellitus	0.00289	0.00297	CcSEcCtD
Emedastine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00276	0.00284	CcSEcCtD
Emedastine—Tachycardia—Losartan—type 2 diabetes mellitus	0.00275	0.00282	CcSEcCtD
Emedastine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00272	0.00279	CcSEcCtD
Emedastine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00268	0.00276	CcSEcCtD
Emedastine—Rash—Glyburide—type 2 diabetes mellitus	0.00266	0.00273	CcSEcCtD
Emedastine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00266	0.00273	CcSEcCtD
Emedastine—Headache—Glyburide—type 2 diabetes mellitus	0.00264	0.00272	CcSEcCtD
Emedastine—Pain—Irbesartan—type 2 diabetes mellitus	0.00256	0.00263	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.0025	0.00257	CcSEcCtD
Emedastine—Asthenia—Valsartan—type 2 diabetes mellitus	0.0025	0.00257	CcSEcCtD
Emedastine—Discomfort—Ramipril—type 2 diabetes mellitus	0.00249	0.00256	CcSEcCtD
Emedastine—Asthenia—Orlistat—type 2 diabetes mellitus	0.00247	0.00254	CcSEcCtD
Emedastine—Pruritus—Valsartan—type 2 diabetes mellitus	0.00246	0.00253	CcSEcCtD
Emedastine—Pruritus—Orlistat—type 2 diabetes mellitus	0.00243	0.0025	CcSEcCtD
Emedastine—Pain—Losartan—type 2 diabetes mellitus	0.00241	0.00247	CcSEcCtD
Emedastine—Rash—Gliclazide—type 2 diabetes mellitus	0.00239	0.00246	CcSEcCtD
Emedastine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00239	0.00245	CcSEcCtD
Emedastine—Headache—Gliclazide—type 2 diabetes mellitus	0.00237	0.00244	CcSEcCtD
Emedastine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.00237	0.00243	CcSEcCtD
Emedastine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.00235	0.00242	CcSEcCtD
Emedastine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00234	0.00241	CcSEcCtD
Emedastine—Asthenia—Metformin—type 2 diabetes mellitus	0.00227	0.00234	CcSEcCtD
Emedastine—Pruritus—Metformin—type 2 diabetes mellitus	0.00224	0.00231	CcSEcCtD
Emedastine—Rash—Valsartan—type 2 diabetes mellitus	0.00219	0.00226	CcSEcCtD
Emedastine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00219	0.00225	CcSEcCtD
Emedastine—Headache—Valsartan—type 2 diabetes mellitus	0.00218	0.00224	CcSEcCtD
Emedastine—Rash—Orlistat—type 2 diabetes mellitus	0.00217	0.00223	CcSEcCtD
Emedastine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00217	0.00223	CcSEcCtD
Emedastine—Headache—Orlistat—type 2 diabetes mellitus	0.00215	0.00221	CcSEcCtD
Emedastine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00215	0.00221	CcSEcCtD
Emedastine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00212	0.00218	CcSEcCtD
Emedastine—Asthenia—Losartan—type 2 diabetes mellitus	0.00202	0.00208	CcSEcCtD
Emedastine—Rash—Metformin—type 2 diabetes mellitus	0.002	0.00205	CcSEcCtD
Emedastine—Dermatitis—Metformin—type 2 diabetes mellitus	0.002	0.00205	CcSEcCtD
Emedastine—Pruritus—Losartan—type 2 diabetes mellitus	0.00199	0.00205	CcSEcCtD
Emedastine—Headache—Metformin—type 2 diabetes mellitus	0.00198	0.00204	CcSEcCtD
Emedastine—Rash—Irbesartan—type 2 diabetes mellitus	0.00189	0.00194	CcSEcCtD
Emedastine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00188	0.00194	CcSEcCtD
Emedastine—Headache—Irbesartan—type 2 diabetes mellitus	0.00187	0.00193	CcSEcCtD
Emedastine—Rash—Losartan—type 2 diabetes mellitus	0.00177	0.00182	CcSEcCtD
Emedastine—Dermatitis—Losartan—type 2 diabetes mellitus	0.00177	0.00182	CcSEcCtD
Emedastine—Headache—Losartan—type 2 diabetes mellitus	0.00176	0.00181	CcSEcCtD
Emedastine—Asthenia—Ramipril—type 2 diabetes mellitus	0.00173	0.00178	CcSEcCtD
Emedastine—Pruritus—Ramipril—type 2 diabetes mellitus	0.00171	0.00176	CcSEcCtD
Emedastine—Rash—Ramipril—type 2 diabetes mellitus	0.00152	0.00156	CcSEcCtD
Emedastine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00152	0.00156	CcSEcCtD
Emedastine—Headache—Ramipril—type 2 diabetes mellitus	0.00151	0.00155	CcSEcCtD
